Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Response to Letter Regarding Article "Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease".

Patel RS, Ghasemzadeh N, Eapen DJ, Sher S, Arshad S, Ko YA, Veledar E, Samady H, Zafari AM, Sperling L, Vaccarino V, Jones DP, Quyyumi AA.

Circulation. 2016 May 31;133(22):e667. doi: 10.1161/CIRCULATIONAHA.116.022753. No abstract available.

PMID:
27245653
2.

Physical activity in the prevention of coronary heart disease: implications for the clinician.

Varghese T, Schultz WM, McCue AA, Lambert CT, Sandesara PB, Eapen DJ, Gordon NF, Franklin BA, Sperling LS.

Heart. 2016 Jun 15;102(12):904-9. doi: 10.1136/heartjnl-2015-308773. Epub 2016 Mar 3. Review.

PMID:
26941396
3.

Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core.

Corban MT, Hung OY, Mekonnen G, Eshtehardi P, Eapen DJ, Rasoul-Arzrumly E, Al Kassem H, Manocha P, Ko YA, Sperling LS, Quyyumi AA, Samady H.

Circ J. 2016;80(4):931-7. doi: 10.1253/circj.CJ-15-0768. Epub 2016 Feb 25.

4.

Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease.

Patel RS, Ghasemzadeh N, Eapen DJ, Sher S, Arshad S, Ko YA, Veledar E, Samady H, Zafari AM, Sperling L, Vaccarino V, Jones DP, Quyyumi AA.

Circulation. 2016 Jan 26;133(4):361-9. doi: 10.1161/CIRCULATIONAHA.115.019790. Epub 2015 Dec 16.

5.

Novel biomarkers for cardiovascular risk assessment: current status and future directions.

MacNamara J, Eapen DJ, Quyyumi A, Sperling L.

Future Cardiol. 2015 Sep;11(5):597-613. doi: 10.2217/fca.15.39. Epub 2015 Oct 7.

PMID:
26491788
6.

Low testosterone in men predicts impaired arterial elasticity and microvascular function.

Corrigan FE 3rd, Al Mheid I, Eapen DJ, Hayek SS, Sher S, Martin GS, Quyyumi AA.

Int J Cardiol. 2015 Sep 1;194:94-9. doi: 10.1016/j.ijcard.2015.05.065. Epub 2015 May 12.

PMID:
26022684
7.

Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.

Mekonnen G, Corban MT, Hung OY, Eshtehardi P, Eapen DJ, Al-Kassem H, Rasoul-Arzrumly E, Gogas BD, McDaniel MC, Pielak T, Thorball CW, Sperling L, Quyyumi AA, Samady H.

Atherosclerosis. 2015 Mar;239(1):55-60. doi: 10.1016/j.atherosclerosis.2014.12.025. Epub 2014 Dec 20.

PMID:
25574858
8.

Plasma stromal cell-derived factor 1α/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease.

Ghasemzadeh N, Hritani AW, De Staercke C, Eapen DJ, Veledar E, Al Kassem H, Khayata M, Zafari AM, Sperling L, Hooper C, Vaccarino V, Mavromatis K, Quyyumi AA.

Atherosclerosis. 2015 Jan;238(1):113-8. doi: 10.1016/j.atherosclerosis.2014.10.094. Epub 2014 Oct 29.

9.

Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.

Eapen DJ, Manocha P, Ghasemzadeh N, Patel RS, Al Kassem H, Hammadah M, Veledar E, Le NA, Pielak T, Thorball CW, Velegraki A, Kremastinos DT, Lerakis S, Sperling L, Quyyumi AA.

J Am Heart Assoc. 2014 Oct 23;3(5):e001118. doi: 10.1161/JAHA.114.001118. Erratum in: J Am Heart Assoc. 2015 Jan;4(1):e000563. Ghasemzedah, Nima [Corrected to Ghasemzadeh, Nima].

10.

Statins in the elderly: a patient-focused approach.

Wilmot KA, Khan A, Krishnan S, Eapen DJ, Sperling L.

Clin Cardiol. 2015 Jan;38(1):56-61. doi: 10.1002/clc.22338. Epub 2014 Oct 21. Review.

11.

Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.

Patel RS, Li Q, Ghasemzadeh N, Eapen DJ, Moss LD, Janjua AU, Manocha P, Al Kassem H, Veledar E, Samady H, Taylor WR, Zafari AM, Sperling L, Vaccarino V, Waller EK, Quyyumi AA.

Circ Res. 2015 Jan 16;116(2):289-97. doi: 10.1161/CIRCRESAHA.116.304187. Epub 2014 Oct 16.

12.

Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death.

Kim J, Ghasemzadeh N, Eapen DJ, Chung NC, Storey JD, Quyyumi AA, Gibson G.

Genome Med. 2014 May 30;6(5):40. doi: 10.1186/gm560. eCollection 2014.

13.

Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events.

Shah AJ, Ghasemzadeh N, Zaragoza-Macias E, Patel R, Eapen DJ, Neeland IJ, Pimple PM, Zafari AM, Quyyumi AA, Vaccarino V.

J Am Heart Assoc. 2014 Jun 18;3(3):e000741. doi: 10.1161/JAHA.113.000741.

14.

Oxidative stress is associated with increased pulmonary artery systolic pressure in humans.

Ghasemzadeh N, Patel RS, Eapen DJ, Veledar E, Al Kassem H, Manocha P, Khayata M, Zafari AM, Sperling L, Jones DP, Quyyumi AA.

Hypertension. 2014 Jun;63(6):1270-5. doi: 10.1161/HYPERTENSIONAHA.113.02360. Epub 2014 Mar 10.

15.

Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes.

Eapen DJ, Manocha P, Patel RS, Hammadah M, Veledar E, Wassel C, Nanjundappa RA, Sikora S, Malayter D, Wilson PW, Sperling L, Quyyumi AA, Epstein SE.

J Am Coll Cardiol. 2013 Jul 23;62(4):329-37. doi: 10.1016/j.jacc.2013.03.072. Epub 2013 May 9.

16.

Right coronary artery aneurysm communication with the right atrium following non-st-elevation myocardial infarction treated with coil embolization.

Bhatia NK, Eapen DJ, Stewart JP, Babaliaros V, Sperling LS.

Circulation. 2013 Apr 9;127(14):e537-8. doi: 10.1161/CIRCULATIONAHA.112.095505. No abstract available.

17.

Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism.

Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T, Jones GT, van Rij AM, Eapen DJ, Baas AF, Tregouet DA, Morange PE, Emmerich J, Lindblad B, Gottsäter A, Kiemeny LA, Lindholt JS, Sakalihasan N, Ferrell RE, Carey DJ, Elmore JR, Tsao PS, Grarup N, Jørgensen T, Witte DR, Hansen T, Pedersen O, Pola R, Gaetani E, Magnadottir HB, Wijmenga C, Tromp G, Ronkainen A, Ruigrok YM, Blankensteijn JD, Mueller T, Wells PS, Corral J, Soria JM, Souto JC, Peden JF, Jalilzadeh S, Mayosi BM, Keavney B, Strawbridge RJ, Sabater-Lleal M, Gertow K, Baldassarre D, Nyyssönen K, Rauramaa R, Smit AJ, Mannarino E, Giral P, Tremoli E, de Faire U, Humphries SE, Hamsten A, Haraldsdottir V, Olafsson I, Magnusson MK, Samani NJ, Levey AI, Markus HS, Kostulas K, Dichgans M, Berger K, Kuhlenbäumer G, Ringelstein EB, Stoll M, Seedorf U, Rothwell PM, Powell JT, Kuivaniemi H, Onundarson PT, Valdimarsson E, Matthiasson SE, Gudbjartsson DF, Thorgeirsson G, Quyyumi AA, Watkins H, Farrall M, Thorsteinsdottir U, Stefansson K.

J Am Coll Cardiol. 2012 Aug 21;60(8):722-9. doi: 10.1016/j.jacc.2012.01.078.

18.

Optimal lipid targets for the new era of cardiovascular prevention.

Ramjee V, Eapen DJ, Sperling LS.

Ann N Y Acad Sci. 2012 Apr;1254:106-14. doi: 10.1111/j.1749-6632.2012.06478.x. Review.

PMID:
22548576
19.

Metastatic carcinoid disease inducing coronary vasospasm.

Eapen DJ, Clements S Jr, Block P, Sperling L.

Tex Heart Inst J. 2012;39(1):76-8.

20.

Management of familial hypercholesterolemia during pregnancy: case series and discussion.

Eapen DJ, Valiani K, Reddy S, Sperling L.

J Clin Lipidol. 2012 Jan-Feb;6(1):88-91. doi: 10.1016/j.jacl.2011.08.005. Epub 2011 Sep 21.

PMID:
22264579
Items per page

Supplemental Content

Loading ...
Write to the Help Desk